Fabio Cappuccini
Gynecologic Oncology · Orange, CANPI 1255346763
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $229,019 of the $313,051 with a category attached, or 73.2%. 10 manufacturers reported payments, led by GSK at 46.1% of the total. Reporting peaked in 2022 at $103,299 and has fallen 80.0% since, to $20,692 in 2024. Among gynecologic oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 293 payments — averaging $1068.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$144K
- Eisai Inc.$89K
- Tesaro, Inc.$36K
- AstraZeneca$27K
- Merck$15K
- Clovis Oncology, Inc.$587
- plus $388 from 4 others
Across 27 payments — averaging $28,854 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$602K
- GSK$117K
- Immunogen, Inc.$35K
- Karyopharm Therapeutics Inc.$22K
- Genentech, Inc.$4K
- Merck$247
What the payments were for
- Consulting fees$34,67111%
- Speaking & faculty fees$229,01973%
- Travel & lodging$40,80613%
- Food & beverage$8,4833%
- Education$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 106 | $144,234 |
| Eisai Inc. | 76 | $89,390 |
| Tesaro, Inc. | 48 | $36,483 |
| AstraZeneca | 37 | $26,735 |
| Merck | 16 | $15,234 |
| Clovis Oncology, Inc. | 4 | $587 |
| Biom'up SA | 1 | $149 |
| Pacira Pharmaceuticals Incorporated | 1 | $105 |
| Immunogen, Inc. | 2 | $74 |
| Myriad Genetic Laboratories, Inc. | 2 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$313,051 in reported general payments places this provider in the 95th percentile of 152 gynecologic oncology providers in California.
Other gynecologic oncology in Orange
- Krishnansu TewariOrange$495K
- Jill TsengOrange$14K
- John ChanSan Francisco$2M
- Dana ChaseLos Angeles$1.3M
- Ramez EskanderEncinitas$706K
- Mehdi Moslemi-KebriaUpland$225K
- Amer KaramStanford$168K
- Rebecca BrooksSacramento$133K
- Kenneth KimWest Hollywood$88K
- Oliver DorigoStanford$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.